• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗体在肾移植中不断扩大的作用。

Expanding role of antibodies in kidney transplantation.

作者信息

Abbas Khawar, Mubarak Muhammed

机构信息

Department of Transplant Immunology, Sindh Institute of Urology & Transplantation, Karachi 74200, Sindh, Pakistan.

Javed I. Kazi Department of Histopathology, Sindh Institute of Urology & Transplantation, Karachi 74200, Sindh, Pakistan.

出版信息

World J Transplant. 2025 Mar 18;15(1):99220. doi: 10.5500/wjt.v15.i1.99220.

DOI:10.5500/wjt.v15.i1.99220
PMID:40104192
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11612895/
Abstract

The role of antibodies in kidney transplant (KT) has evolved significantly over the past few decades. This role of antibodies in KT is multifaceted, encompassing both the challenges they pose in terms of antibody-mediated rejection (AMR) and the opportunities for improving transplant outcomes through better detection, prevention, and treatment strategies. As our understanding of the immunological mechanisms continues to evolve, so too will the approaches to managing and harnessing the power of antibodies in KT, ultimately leading to improved patient and graft survival. This narrative review explores the multifaceted roles of antibodies in KT, including their involvement in rejection mechanisms, advancements in desensitization protocols, AMR treatments, and their potential role in monitoring and improving graft survival.

摘要

在过去几十年中,抗体在肾移植(KT)中的作用发生了显著演变。抗体在肾移植中的这一作用是多方面的,既包括它们在抗体介导的排斥反应(AMR)方面带来的挑战,也包括通过更好的检测、预防和治疗策略改善移植结果的机会。随着我们对免疫机制的理解不断发展,肾移植中管理和利用抗体作用的方法也将不断演进,最终提高患者和移植物的存活率。这篇叙述性综述探讨了抗体在肾移植中的多方面作用,包括它们在排斥机制中的参与、脱敏方案的进展、抗体介导的排斥反应治疗以及它们在监测和改善移植物存活方面的潜在作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5da/11612895/8812a9e6b880/99220-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5da/11612895/948e8a447ff2/99220-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5da/11612895/a8ee11c306df/99220-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5da/11612895/89395dc6ad7d/99220-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5da/11612895/8812a9e6b880/99220-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5da/11612895/948e8a447ff2/99220-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5da/11612895/a8ee11c306df/99220-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5da/11612895/89395dc6ad7d/99220-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5da/11612895/8812a9e6b880/99220-g004.jpg

相似文献

1
Expanding role of antibodies in kidney transplantation.抗体在肾移植中不断扩大的作用。
World J Transplant. 2025 Mar 18;15(1):99220. doi: 10.5500/wjt.v15.i1.99220.
2
Successful eculizumab treatment as an adjunctive therapy to desensitization in ABO-incompatible living donor kidney transplantation and its molecular phenotypes.成功的依库珠单抗治疗作为 ABO 不相容活体供肾移植中脱敏治疗的辅助治疗及其分子表型。
Front Immunol. 2024 Oct 28;15:1465851. doi: 10.3389/fimmu.2024.1465851. eCollection 2024.
3
Desensitization for prevention of chronic antibody-mediated rejection after kidney transplantation.肾移植后预防慢性抗体介导排斥反应的脱敏治疗。
Clin Transplant. 2013 Nov-Dec;27 Suppl 26:2-8. doi: 10.1111/ctr.12260.
4
Effect of blood transfusion post kidney transplantation on de novo human leukocytes antigen donor-specific antibody development and clinical outcomes in kidney transplant recipients: A systematic review and meta-analysis.肾移植后输血对肾移植受者新发人类白细胞抗原供者特异性抗体产生及临床结局的影响:一项系统评价和荟萃分析
Transpl Immunol. 2023 Jun;78:101801. doi: 10.1016/j.trim.2023.101801. Epub 2023 Feb 24.
5
Effect of anti-angiotensin II type 1 receptor antibodies on the outcomes of kidney transplantation: a systematic review and meta-analysis.抗血管紧张素 II 型 1 型受体抗体对肾移植结局的影响:系统评价和荟萃分析。
Nephrol Dial Transplant. 2022 May 25;37(6):1171-1180. doi: 10.1093/ndt/gfab344.
6
Polyclonal and monoclonal antibodies for treating acute rejection episodes in kidney transplant recipients.用于治疗肾移植受者急性排斥反应的多克隆抗体和单克隆抗体。
Cochrane Database Syst Rev. 2017 Jul 20;7(7):CD004756. doi: 10.1002/14651858.CD004756.pub4.
7
Living Donor Kidney Transplantation in Patients With Donor-Specific HLA Antibodies After Desensitization With Immunoadsorption.免疫吸附脱敏后具有供体特异性 HLA 抗体患者的活体供肾移植
Front Med (Lausanne). 2021 Dec 17;8:781491. doi: 10.3389/fmed.2021.781491. eCollection 2021.
8
Levels of angiotensin II type-1 receptor antibodies and endothelin-1 type-A receptor antibodies correlate with antibody-mediated rejection and poor graft function in kidney-transplantation patients.肾移植患者体内血管紧张素II 1型受体抗体和内皮素-1 A型受体抗体水平与抗体介导的排斥反应及移植肾功能不佳相关。
Transpl Immunol. 2022 Oct;74:101674. doi: 10.1016/j.trim.2022.101674. Epub 2022 Jul 25.
9
Computational Prediction of Biomarkers, Pathways, and New Target Drugs in the Pathogenesis of Immune-Based Diseases Regarding Kidney Transplantation Rejection.基于免疫性疾病的发病机制的肾移植排斥反应的生物标志物、通路和新型靶标药物的计算预测。
Front Immunol. 2021 Dec 15;12:800968. doi: 10.3389/fimmu.2021.800968. eCollection 2021.
10
Antibody-Mediated Rejection in Kidney Transplantation: A Retrospective Study on the Impact of Donor-Specific Antibodies and on the Timing of Diagnosis.肾移植中抗体介导的排斥反应:关于供体特异性抗体影响及诊断时机的回顾性研究
Cureus. 2022 Oct 14;14(10):e30296. doi: 10.7759/cureus.30296. eCollection 2022 Oct.

本文引用的文献

1
New treatment for antibody-mediated rejection: interleukin-6 inhibitors.抗体介导性排斥反应的新疗法:白细胞介素-6抑制剂
Clin Transplant Res. 2024 Mar 31;38(1):1-6. doi: 10.4285/ctr.23.0069.
2
The Banff 2022 Kidney Meeting Report: Reappraisal of microvascular inflammation and the role of biopsy-based transcript diagnostics.班夫 2022 年肾脏会议报告:重新评估微血管炎症和基于活检的转录诊断学的作用。
Am J Transplant. 2024 Mar;24(3):338-349. doi: 10.1016/j.ajt.2023.10.016. Epub 2023 Oct 28.
3
Evolution of human kidney allograft pathology diagnostics through 30 years of the Banff classification process.
通过30年的班夫分类过程看人类肾移植病理诊断的演变
World J Transplant. 2023 Sep 18;13(5):221-238. doi: 10.5500/wjt.v13.i5.221.
4
Molecular immune monitoring in kidney transplant rejection: a state-of-the-art review.肾移植排斥反应的分子免疫监测:最新综述。
Front Immunol. 2023 Aug 22;14:1206929. doi: 10.3389/fimmu.2023.1206929. eCollection 2023.
5
Emerging Therapies for Antibody-Mediated Rejection in Kidney Transplantation.肾移植中抗体介导排斥反应的新兴治疗方法
J Clin Med. 2023 Jul 26;12(15):4916. doi: 10.3390/jcm12154916.
6
Immune landscape in rejection of renal transplantation revealed by high-throughput single-cell RNA sequencing.高通量单细胞RNA测序揭示肾移植排斥反应中的免疫图谱
Front Cell Dev Biol. 2023 Jul 20;11:1208566. doi: 10.3389/fcell.2023.1208566. eCollection 2023.
7
Impact of pre-transplant donor specific antibodies detected by Luminex with negative microlymphocytotoxicity assay and flow crossmatch in live-related renal transplant recipients.微淋巴细胞毒性试验和流式细胞交叉配型阴性时 Luminex 检测到的移植前供体特异性抗体对活体相关肾移植受者的影响。
Clin Transplant. 2023 May;37(5):e14935. doi: 10.1111/ctr.14935. Epub 2023 Feb 23.
8
Progress in kidney transplantation: The role for systems immunology.肾移植的进展:系统免疫学的作用
Front Med (Lausanne). 2022 Dec 16;9:1070385. doi: 10.3389/fmed.2022.1070385. eCollection 2022.
9
Alloimmune risk assessment for antibody-mediated rejection in kidney transplantation: A practical proposal.肾移植中抗体介导排斥反应的同种免疫风险评估:一项实用建议。
Transplant Rev (Orlando). 2023 Jan;37(1):100745. doi: 10.1016/j.trre.2022.100745. Epub 2022 Dec 20.
10
Dissecting the impact of molecular T-cell HLA mismatches in kidney transplant failure: A retrospective cohort study.剖析分子 T 细胞 HLA 错配对肾移植失败的影响:一项回顾性队列研究。
Front Immunol. 2022 Nov 24;13:1067075. doi: 10.3389/fimmu.2022.1067075. eCollection 2022.